Methods of delivering factor VIII encoding nucleic acid sequences
There is provided a nucleic acid molecule comprising a nucleotide sequence encoding a factor VIII protein, wherein a B domain portion of the factor VIII protein is encoded by a nucleotides sequence between 90 and 111 nucleotides in length and has an amino acid sequence that is at least 85% identical to SEQ ID NO: 4 which comprises six asparagine residues. Also provided is a factor VIII protein, a vector comprising the above nucleic acid molecule, a host cell, a transgenic animal, a method of treating Haemophilia A, and a method for the preparation of a parvoviral gene delivery vector.
1. A method for administering to a subject a nucleic acid molecule encoding a Factor VIII protein, comprising:
intravenously administering to the subject a nucleic acid molecule encoding a Factor VIII protein, wherein the Factor VIII protein B domain comprises a spacer that is replaced and wherein the B domain comprises the amino acid sequence set forth in SEQ ID NO:4.
2. The method of claim 1 , wherein the B domain of said Factor VIII protein is between 30 and 37 amino acids in length.
3. The method of claim 1 , wherein the B domain of said Factor VIII protein is 31 amino acids in length.
4. The method of claim 1 , wherein the B domain of said Factor VIII protein comprises the amino acid sequence of SEQ ID NO:5.
5. The method of claim 1 , wherein the B domain of said Factor VIII protein consists of the amino acid sequence of SEQ ID NO:5.
6. The method of claim 1 , wherein the Factor VIII protein encoded by the nucleic acid molecule comprises domains A1, A2, A3, C1 and C2, and wherein the nucleic acid molecule is codon optimised compared to a corresponding wild type sequence.
7. The method of claim 1 , wherein said Factor VIII protein comprises the amino acid sequence of SEQ ID NO:6.
8. The method of claim 1 , wherein said nucleic acid molecule encoding said Factor VIII protein comprises the nucleic acid sequence of SEQ ID NO:3.